Latest News about IPHA
Recent news which mentions IPHA
From Benzinga
Why Virios Therapeutics Is Trading Lower By Over 71%, Here Are 55 Stocks Moving In Monday's Mid-Day Session
September 19, 2022
From Benzinga
12 Health Care Stocks Moving In Monday's Pre-Market Session
September 19, 2022
From Benzinga
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Monday
September 19, 2022
From InvestorPlace
Why bluebird bio Is Trading Higher By Around 19%; Here Are 31 Stocks Moving Premarket
September 19, 2022
From Benzinga
Earnings Scheduled For September 15, 2022
September 15, 2022
From Benzinga
From Benzinga
This Biotechnology Stock Is Trading Lower By 77%, Here Are 62 Stocks Moving In Monday's Mid-Day Session
August 01, 2022
From Benzinga
Daily Biotech Pulse: Celyad Resumes Colorectal Cancer Trial, Setback For Otonomy, AstraZeneca Halts Phase 3 Head, Neck Cancer Trial
August 01, 2022
From Benzinga
From Benzinga
12 Health Care Stocks Moving In Monday's Pre-Market Session
August 01, 2022
From Benzinga
From InvestorPlace
Why Celyad Oncology Is Trading Higher By Over 31%; Here Are 29 Stocks Moving Premarket
August 01, 2022
From Benzinga
67 Biggest Movers From Yesterday
June 22, 2022
From Benzinga
89 Biggest Movers From Friday
June 21, 2022
From Benzinga
70 Biggest Movers From Friday
May 02, 2022
From Benzinga
48 Stocks Moving In Friday's Mid-Day Session
April 29, 2022
From Benzinga
From Benzinga
28 Stocks Moving in Friday's Pre-Market Session
April 29, 2022
From Benzinga
Earnings Scheduled For March 24, 2022
March 24, 2022
From Benzinga
From Benzinga
From Benzinga
20 Stocks Moving in Tuesday's Pre-Market Session
January 25, 2022
From Benzinga
The Daily Biotech Pulse: Pfizer-BioNTech Partner For Shingles Vaccine, Annexon Huntington Disease Study Disappoints, Amneal Buys Neurology Assets
January 05, 2022
From Benzinga
18 Stocks Moving in Monday's Pre-Market Session
January 03, 2022
From Benzinga
Innate Pharma Says Chemo-Free Monalizumab Triplet Therapy Shows Preliminary Anti-Cancer Activity
December 09, 2021
From Benzinga
The Daily Biotech Pulse: Reata Plunges On Adcom Snub, AstraZeneca Antibody Cocktail Authorized For COVID-19 Prevention, NeuroSense IPO
December 09, 2021
From Benzinga
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.